Epoprostenol Na (Epoprostenol Na)
Overview of Epoprostenol Na
During cardiac bypass procedures and charcoal hemoperfusion, Epoprostenol (Na) is used to preserve the platelet function. It may be used as an anticoagulant, as an alternative to heparin in renal dialysis.
Indication of Epoprostenol Na
Epoprostenol Na is primarily indicated in conditions like Adult respiratory distress syndrome (ards), Coronary artery disease, Heart failure, Peripheral vascular disease, Primary pulmonary hypertension, Raynaud's phenomenon.
Contraindication of Epoprostenol Na
Epoprostenol (Na) is contraindicated in conditions like Hemorrhagic diathesis.
Side Effects of Epoprostenol Na
Epoprostenol (Na) produces potentially life-threatening effects which include Bradycardia, Vaso-vagal attacks, Low cardiac output, Severe hypertension. which are responsible for the discontinuation of Epoprostenol (Na) therapy.,The signs and symptoms that are produced after the acute overdosage of Epoprostenol (Na) include Hypotension, Nausea, Vomiting, Headache, Abdominal cramps, Severe flushing.,The symptomatic adverse reactions produced by Epoprostenol (Na) are more or less tolerable and if they become severe, they can be treated symptomatically, these include Headache, Nausea, Vomiting, Flushing, Abdominal colic.
Precautions of Epoprostenol Na
Abrupt discontinuation of epoprostenol therapy, including sudden reductions in dosage and interuptions in drug delivery may result in symptoms of rebound pulmonary hypertension. Epoprostenol can cause hypotension, it should be used cautiously with other hypotensive drugs to avoid additive effects. Epoprostenol should not be used chronically in patients who develop pulmonary edema (may be associated with veno-occlusive disease) during dose ranging.